Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?

Magdy El Ekiaby; Junko Tanaka; Harry van Drimmelen; Jean‐Pierre Allain; Nico Lelie

doi:10.1111/jvh.13990

August 10, 2024Journal of Viral Hepatitis

Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?

View Full Paper

Ask AI

Bookmark

Share

Key Points

Hepatitis B virus surface antigen-positive plasma can retain infectivity despite undetectable viral DNA, posing residual transmission risks during transfusions.
Review of hepatitis B virus infectivity data assessed the fifty percent infectious dose, examining transmission potential when viral DNA falls below limits of detection.
Evaluation highlights that discontinuing surface antigen screening among blood donors may be premature, supporting continued antigen surveillance for blood safety.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Review finds hepatitis B virus transmission risk from antigen-positive plasma lacking detectable viral DNA in blood donors, highlighting why surface antigen screening should continue.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ekiaby et al. (2024) studied this question.

synapsesocial.com/papers/68e5cc74b6db643587562f34 https://doi.org/10.1111/jvh.13990

View Full Paper

Ask AI

Bookmark

Share

Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading